APO Research

APO RESEARCH · REPORT

Pediculosis and Pthiriasis (Lice Infestation) Treatment

Selected research

Market Outlook & Growth Opportunities

Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Outlook and Growth Opportunities 2026

Market perspective

The global Pediculosis and Pthiriasis (Lice Infestation) Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pediculosis and Pthiriasis (Lice Infestation) Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pediculosis and Pthiriasis (Lice Infestation) Treatment market include Actavis, Arborpharma, Logic Products, Major Pharmaceuticals, Omega Pharma, ParaPRO, Perrigo, Prestige Brands and Reckitt Benckier, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediculosis and Pthiriasis (Lice Infestation) Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediculosis and Pthiriasis (Lice Infestation) Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market.

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Company

Actavis

Arborpharma

Logic Products

Major Pharmaceuticals

Omega Pharma

ParaPRO

Perrigo

Prestige Brands

Reckitt Benckier

Shionogi

TecLabs

Thornton and Ross

Tianren

Tyratech

Bayer

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Type

Lotion

Shampoo

Creams

Other

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Application

Children

Adult

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pediculosis and Pthiriasis (Lice Infestation) Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pediculosis and Pthiriasis (Lice Infestation) Treatment key companies, revenue, market share, and recent developments.

3. To split the Pediculosis and Pthiriasis (Lice Infestation) Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pediculosis and Pthiriasis (Lice Infestation) Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pediculosis and Pthiriasis (Lice Infestation) Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Pediculosis and Pthiriasis (Lice Infestation) Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediculosis and Pthiriasis (Lice Infestation) Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediculosis and Pthiriasis (Lice Infestation) Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pediculosis and Pthiriasis (Lice Infestation) Treatment industry.

Chapter 3: Detailed analysis of Pediculosis and Pthiriasis (Lice Infestation) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pediculosis and Pthiriasis (Lice Infestation) Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pediculosis and Pthiriasis (Lice Infestation) Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Trends Table 2. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Drivers Table 3. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Opportunities and Challenges Table 4. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Restraints Table 5. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Company (2021-2026) Table 7. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company, Product Type & Application Table 10. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Lotion Table 15. Significant Companies of Shampoo Table 16. Significant Companies of Creams Table 17. Significant Companies of Other Table 18. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type (2021-2026) Table 22. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Children Table 24. Significant Companies of Adult Table 25. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application (2021-2026) Table 29. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application (2027-2032) Table 30. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Region (2021-2026) Table 33. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Region (2027-2032) Table 35. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Market Share by Country (2027-2032) Table 40. Actavis Company Information Table 41. Actavis Business Overview Table 42. Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 44. Actavis Recent Development Table 45. Arborpharma Company Information Table 46. Arborpharma Business Overview Table 47. Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 49. Arborpharma Recent Development Table 50. Logic Products Company Information Table 51. Logic Products Business Overview Table 52. Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 54. Logic Products Recent Development Table 55. Major Pharmaceuticals Company Information Table 56. Major Pharmaceuticals Business Overview Table 57. Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 59. Major Pharmaceuticals Recent Development Table 60. Omega Pharma Company Information Table 61. Omega Pharma Business Overview Table 62. Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 64. Omega Pharma Recent Development Table 65. ParaPRO Company Information Table 66. ParaPRO Business Overview Table 67. ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 69. ParaPRO Recent Development Table 70. Perrigo Company Information Table 71. Perrigo Business Overview Table 72. Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 74. Perrigo Recent Development Table 75. Prestige Brands Company Information Table 76. Prestige Brands Business Overview Table 77. Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 79. Prestige Brands Recent Development Table 80. Reckitt Benckier Company Information Table 81. Reckitt Benckier Business Overview Table 82. Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 84. Reckitt Benckier Recent Development Table 85. Shionogi Company Information Table 86. Shionogi Business Overview Table 87. Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 89. Shionogi Recent Development Table 90. TecLabs Company Information Table 91. TecLabs Business Overview Table 92. TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 94. TecLabs Recent Development Table 95. Thornton and Ross Company Information Table 96. Thornton and Ross Business Overview Table 97. Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 99. Thornton and Ross Recent Development Table 100. Tianren Company Information Table 101. Tianren Business Overview Table 102. Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 104. Tianren Recent Development Table 105. Tyratech Company Information Table 106. Tyratech Business Overview Table 107. Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 109. Tyratech Recent Development Table 110. Bayer Company Information Table 111. Bayer Business Overview Table 112. Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 114. Bayer Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Image Figure 2. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Lotion Image Figure 8. Shampoo Image Figure 9. Creams Image Figure 10. Other Image Figure 11. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type (2021-2032) Figure 14. Children Image Figure 15. Adult Image Figure 16. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Lotion
  • Shampoo
  • Creams
  • Other
Applications
  • Children
  • Adult
Companies covered
  • Actavis
  • Arborpharma
  • Logic Products
  • Major Pharmaceuticals
  • Omega Pharma
  • ParaPRO
  • Perrigo
  • Prestige Brands
  • Reckitt Benckier
  • Shionogi
  • TecLabs
  • Thornton and Ross
  • Tianren
  • Tyratech
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Dynamics
  1. 2.1 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Trends
  2. 2.2 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Drivers
  3. 2.3 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Opportunities and Challenges
  4. 2.4 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Restraints
3 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Company
  1. 3.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Ranking (2024-2026)
  4. 3.4 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Product Type and Application
  6. 3.6 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pediculosis and Pthiriasis (Lice Infestation) Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Type
  1. 4.1 Pediculosis and Pthiriasis (Lice Infestation) Treatment Type Introduction
  2. 4.1.1 Lotion
  3. 4.1.2 Shampoo
  4. 4.1.3 Creams
  5. 4.1.4 Other
  6. 4.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type
  7. 4.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type (2021-2032)
5 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Application
  1. 5.1 Pediculosis and Pthiriasis (Lice Infestation) Treatment Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application
  5. 5.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application (2021-2032)
6 Pediculosis and Pthiriasis (Lice Infestation) Treatment Regional Value Analysis
  1. 6.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
7 Pediculosis and Pthiriasis (Lice Infestation) Treatment Country-level Value Analysis
  1. 7.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis
  2. 8.1.1 Actavis Company Information
  3. 8.1.2 Actavis Business Overview
  4. 8.1.3 Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  6. 8.1.5 Actavis Recent Developments
  7. 8.2 Arborpharma
  8. 8.2.1 Arborpharma Company Information
  9. 8.2.2 Arborpharma Business Overview
  10. 8.2.3 Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  12. 8.2.5 Arborpharma Recent Developments
  13. 8.3 Logic Products
  14. 8.3.1 Logic Products Company Information
  15. 8.3.2 Logic Products Business Overview
  16. 8.3.3 Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  18. 8.3.5 Logic Products Recent Developments
  19. 8.4 Major Pharmaceuticals
  20. 8.4.1 Major Pharmaceuticals Company Information
  21. 8.4.2 Major Pharmaceuticals Business Overview
  22. 8.4.3 Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  24. 8.4.5 Major Pharmaceuticals Recent Developments
  25. 8.5 Omega Pharma
  26. 8.5.1 Omega Pharma Company Information
  27. 8.5.2 Omega Pharma Business Overview
  28. 8.5.3 Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  30. 8.5.5 Omega Pharma Recent Developments
  31. 8.6 ParaPRO
  32. 8.6.1 ParaPRO Company Information
  33. 8.6.2 ParaPRO Business Overview
  34. 8.6.3 ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  36. 8.6.5 ParaPRO Recent Developments
  37. 8.7 Perrigo
  38. 8.7.1 Perrigo Company Information
  39. 8.7.2 Perrigo Business Overview
  40. 8.7.3 Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  42. 8.7.5 Perrigo Recent Developments
  43. 8.8 Prestige Brands
  44. 8.8.1 Prestige Brands Company Information
  45. 8.8.2 Prestige Brands Business Overview
  46. 8.8.3 Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  48. 8.8.5 Prestige Brands Recent Developments
  49. 8.9 Reckitt Benckier
  50. 8.9.1 Reckitt Benckier Company Information
  51. 8.9.2 Reckitt Benckier Business Overview
  52. 8.9.3 Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  54. 8.9.5 Reckitt Benckier Recent Developments
  55. 8.10 Shionogi
  56. 8.10.1 Shionogi Company Information
  57. 8.10.2 Shionogi Business Overview
  58. 8.10.3 Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  60. 8.10.5 Shionogi Recent Developments
  61. 8.11 TecLabs
  62. 8.11.1 TecLabs Company Information
  63. 8.11.2 TecLabs Business Overview
  64. 8.11.3 TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  66. 8.11.5 TecLabs Recent Developments
  67. 8.12 Thornton and Ross
  68. 8.12.1 Thornton and Ross Company Information
  69. 8.12.2 Thornton and Ross Business Overview
  70. 8.12.3 Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  72. 8.12.5 Thornton and Ross Recent Developments
  73. 8.13 Tianren
  74. 8.13.1 Tianren Company Information
  75. 8.13.2 Tianren Business Overview
  76. 8.13.3 Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  78. 8.13.5 Tianren Recent Developments
  79. 8.14 Tyratech
  80. 8.14.1 Tyratech Company Information
  81. 8.14.2 Tyratech Business Overview
  82. 8.14.3 Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  84. 8.14.5 Tyratech Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  90. 8.15.5 Bayer Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research